Hinge Health, Inc.
Rank #61HypergrowthHNGE · NYSE · Healthcare
Hinge Health, Inc. (HNGE) — Rank #61 by gross profitability (GP/assets 0.57) · ROE -153.4% · Piotroski F-Score 4 / 9.
As-of 2026-09-15 · CIK 0001673743 · all metrics point-in-time as of the filing date.
About
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology.
Show moreShow less
It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers.
The company was founded in 2012 and is headquartered in San Francisco, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- State
- DE
- Filer Category
- Emerging growth company
- Fiscal Year End
- December 31
- Website
- hingehealth.com
Financials
Stable
Direction over 5 fiscal years
- Free cash flowstable
- Gross marginstable
- Gross profitabilitystable
- Net cashstable
- Operating marginstable
- Return on equitystable
- Share count (dilution)stable
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-03-03 | 2024-12-31filed 2026-03-03 | 2023-12-31filed 2026-03-03 |
|---|---|---|---|
| Income statement | |||
| Revenue | 587.9 | 390.4 | 292.7 |
| Revenue growth (YoY) | 50.6% | 50.6% | 50.6% |
| Gross profit | 468.2 | 468.2 | 468.2 |
| Gross margin | 79.6% | 79.6% | 79.6% |
| Net income | (528.3) | (11.9) | (108.1) |
| Net margin | -89.9% | -89.9% | -89.9% |
| EPS (diluted) | -$7.77 | -$0.88 | -$8.31 |
| EPS growth (YoY) | -783.0% | 89.4% | — |
| Cash flow | |||
| Operating cash flow | 171.4 | 49.0 | (63.9) |
| Capital expenditures | 0.7 | — | — |
| Free cash flow | 170.7 | 170.7 | 170.7 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?